- $3.20bn
- $3.08bn
- $319.31m
Annual cashflow statement for Agilysys, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 6.48 | 14.6 | 86.2 | 23.2 | 38.8 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 14.7 | 13 | 13 | 17.8 | 21.8 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 4.31 | 3.53 | 10.1 | 5.67 | -7.79 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 28.5 | 34.5 | 48.2 | 55.1 | 70 |
| Capital Expenditures | -1.2 | -7.24 | -8.13 | -2.78 | -1.85 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -24.5 | 0.368 | 0.525 | -146 | 0 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Cash from Investing Activities | -25.7 | -6.87 | -7.6 | -149 | -1.85 |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -4.9 | -11.1 | -8.56 | 21.9 | -24.5 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.21 | 15.9 | 32 | -71.8 | 43.9 |